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We report that changes of phosphodiesterase-10A (PDE10A) can map widespread functional imbalance of basal ganglia circuits in a
mouse model of DYT1 dystonia overexpressing mutant torsinA. PDE10A is a key enzyme in the catabolism of second messenger cAMP
and cGMP, whose synthesis is stimulated by D1 receptors and inhibited by D2 receptors preferentially expressed in striatoentopeducun-
cular/substantia nigra or striatopallidal pathways, respectively. PDE10A was studied in control mice (NT) and in mice carrying human
wild-type torsinA (hWT) ormutant torsinA (hMT). Quantitative analysis of PDE10A expression was assessed in different brain areas by
rabbit anti-PDE10Aantibody immunohistochemistry andWesternblotting. PDE10A-dependent cAMPhydrolyzing activity andPDE10A
mRNA were also assessed. Striatopallidal neurons were identified by rabbit anti-enkephalin antibody.
In NT mice, PDE10A is equally expressed in medium spiny striatal neurons and in their projections to entopeduncular nucleus/
substantia nigra and to external globus pallidus. In hMT mice, PDE10A content selectively increases in enkephalin-positive striatal
neuronal bodies; moreover, PDE10A expression and activity in hMT mice, compared with NT mice, significantly increase in globus
pallidus but decrease in entopeduncular nucleus/substantia nigra. Similar changes of PDE10A occur in hWTmice, but such changes are
not always significant. However, PDE10AmRNA expression appears comparable among NT, hWT, and hMTmice.
InDYT1 transgenicmice, the inversechangesofPDE10Ainstriatoentopeduncularandstriatopallidalprojectionsmightresultover timeinan
imbalancebetweendirect and indirect pathways forproperly focusingmovement. ThedecreaseofPDE10A in the striatoentopeduncular/nigral
projectionsmight lead to increased intensity and duration of D1-stimulated cAMP/cGMP signaling; conversely, the increase of PDE10A in the
striatopallidal projectionsmight lead to increased intensity and duration ofD2-inhibited cAMP/cGMP signaling.
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Introduction
Dystonia is a heterogeneous movement disorder occurring either
in focal or generalized forms. It is characterized by sustained or
intermittent muscle contractions causing abnormal, often repet-
itive, movements, postures, or both (Fahn et al., 1998; Albanese et
al., 2013). The most common and severe isolated dystonia is
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Significance Statement
InDYT1 transgenicmousemodel of dystonia, PDE10A, a key enzyme in cAMP and cGMP catabolism, is downregulated in striatal
projections to entopeduncular nucleus/substantia nigra, preferentially expressing D1 receptors that stimulate cAMP/cGMP syn-
thesis. Conversely, in DYT1mice, PDE10A is upregulated in striatal projections to globus pallidus, preferentially expressing D2
receptors that inhibit cAMP/cGMP synthesis. The inverse changes to PDE10A in striatoentopeduncular/substantia nigra and
striatopallidal pathways might tightly interact downstream to dopamine receptors, likely resulting over time to increased inten-
sity and duration respectively of D1-stimulated and D2-inhibited cAMP/cGMP signals. Therefore, PDE10A changes in the DYT1
model of dystonia canupset the functional balanceof basal ganglia circuits, affectingdirect and indirect pathways simultaneously.
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caused by a 3 bp deletion (GAG) in the coding region of the
TOR1A (DYT1) gene, which results in a defective protein called
torsinA (Ozelius et al., 1997). Ultrastructural studies are consis-
tent with a presynaptic localization of torsinA protein in the adult
striatum and in other regions, suggesting a role of torsinA in the
modulation of signal transmission (Augood et al., 2003; Rostasy
et al., 2003; Puglisi et al., 2013). However, the physiological func-
tion of torsinA is unclear, though it has been proposed to perform
chaperone-like functions and assist in protein trafficking, as well
as participate in membrane fusion, secretory processing, and nu-
clear envelope dynamics (Goodchild et al., 2013).
Neuropathological investigations have not shown consistent
histopathological abnormalities (Albanese et al., 2013) and the
immunostaining pattern of torsinA in patients with DYT1 dysto-
nia has not been found to be discernibly different from that in
normal brains (Fahn et al., 1998). Moreover, torsinA immunore-
activity is widely distributed throughout striatal neuron popula-
tions without variation of the labeling intensity in a specific
population of striatal neurons in transgenic mouse models car-
rying the gene of human wild-type or mutated torsinA (Martella
et al., 2009).
Similarly, it is not clear which brain regions are primarily
involved in most forms of dystonia, as significant neurodegen-
eration could not be documented in any specific brain areas
(Fahn et al., 1998; Standaert, 2011). Thus, brain regions possibly
involved in dystonia are thought to have functional rather than
structural abnormalities. Indeed, despite the lack of neuropa-
thological indications, neurophysiological and neuroimaging
studies, as well as new genetic insights, suggest that functional
abnormalities in the basal ganglia constitute the basis of dystonia
pathophysiology (Rondot, 1991; Kanovsky´, 2002; Defazio et al.,
2007; Ulug˘ et al., 2011; Goodchild et al., 2013).
On that basis, we hypothesized that phosphodiesterase 10A
(PDE10A), a key enzyme in the catabolism of the second messen-
ger cAMP and cGMP in the brain (Soderling et al., 1999), may be
a good indicator of any functional changes arising in basal ganglia
circuits and may be involved in the pathophysiology of dystonia.
Of note, PDE10A is differentially affected in the basal ganglia of
experimental Parkinson’s and Huntington’s disease models
(Hebb et al., 2004; Giorgi et al., 2011; Leuti et al., 2013). More-
over, recent PET imaging studies show loss of striatal and pallidal
PDE10A in patients with Huntington’s disease (Ahmad et al.,
2014; Niccolini et al., 2015b) or Parkinson’s disease (Niccolini et
al., 2015a ).
PDE10A is an isozyme with unique distribution in the basal
ganglia, within the cell body of medium spiny neurons in the
striatum and nucleus accumbens, and within their axons/termi-
nals in the globus pallidus, the entopeduncular nucleus, and the
substantia nigra pars reticulata (Seeger et al., 2003; Xie et al.,
2006; Giorgi et al., 2011). The globus pallidus and the entopedun-
cular nucleus in rodents correspond to the external and the in-
ternal globus pallidus in humans, respectively, representing
nodal points of the so-called indirect and direct pathways of basal
ganglia circuits (Albin et al., 1989). The striatal projections to the
external and internal globus pallidus have opposite effects on
basal ganglia functions, the one reducing and the other facilitat-
ing the motor activities (Albin et al., 1989; Alexander and
Crutcher, 1990; DeLong, 1990). We evaluated whether torsinA
may specifically affect PDE10A expression and activity in basal
ganglia circuits in transgenic mouse models overexpressing hu-
man wild-type torsinA or human DYT1 torsinA mutation.
Materials and Methods
Transgenic mice, generated as previously reported (Sharma et al.,
2005), were bred at the Santa Lucia Foundation Animal Facility.
The mouse genotype was confirmed as previously described
(Martella et al., 2009; Sciamanna et al., 2011). All efforts were
made to minimize the number of animals used and any potential
suffering. Treatment and handling of mice were performed in
compliance with both European Council and Italian guidelines
(86/609/EEC; Legislative Decree 116/1992). The experimental
protocols were approved by the Animal Ethics Committee of Tor
Vergata University of Rome (Ministerial Decree 153/2001-A and
43/2002-A), and by the Santa Lucia Foundation Animal Care and
Use Committee (Ministerial Decree 9/2006-A), and authorized
by the Italian Ministry of Health (protocol no. 07/2011).
Three groups of male animals were studied: nontransgenic
control mice (NT mice), transgenic mice carrying the gene of
human wild-type torsinA (hWT mice), and transgenic mice car-
rying the gene of human mutated torsinA (hMT mice).
For morphological studies, animals were deeply anesthetized
with tiletamine/zolazepam (80 mg/kg) and xylazine (10 mg/kg)
and transcardially perfused with 1% heparin in 50 ml of 0.1 M
sodium phosphate buffer, and with 250 ml of 4% paraformalde-
hyde in 0.1 M sodium phosphate buffer, pH 7.4. Brains were
immediately removed and postfixed in the same fixative solution
overnight at 4°C. Using an Oxford vibratome, 40-m-thick cor-
onal brain sections were cut across the entire rostrocaudal extent
of the basal ganglia, collected, and stored at 4°C in 0.1 M phos-
phate buffer, which contained 0.02% sodium azide.
For biochemical studies, animals were killed by cervical dislo-
cation, and their brains were rapidly removed and placed on an
ice-cold plate, as previously described (Giorgi et al., 2008). Thick
brain sections were cut with an Oxford vibratome, and the cau-
date–putamen, globus pallidus, substantia nigra, and entopedun-
cular nucleus (Paxinos and Franklin, 2012) were dissected out
rapidly from both hemispheres, promptly frozen in liquid nitro-
gen, and stored at80°C. Although PDE10A is selectively located
in the substantia nigra pars reticulata, this area cannot be macro-
scopically identified and dissected separately from the pars
compacta in brainstem sections, and therefore both areas were
analyzed together.
Selected brain regions were homogenized using a glass ho-
mogenizer (15 strokes, 4°C) in 20 mM Tris-HCl buffer, pH 7.2,
which contained 0.2 mM EGTA, 5 mM -mercaptoethanol, 2%
(v/v) antiprotease mixture, 1 mM PMSF, 5 mM MgCl2, 0.1% Tri-
ton X-100. The homogenates were centrifuged at 14,000 g for
30 min at 4°C, and pellets were resuspended in the homogeniza-
tion buffer and centrifuged at 14,000  g for 30 min (4°C). The
first and second supernatants were then pooled and further pro-
cessed for biochemical analysis.
Histology and PDE10A immunohistochemistry. Coronal
brain sections, including the sensorimotor cerebral cortex,
caudate–putamen, globus pallidus, entopeduncular nucl-
eus, and substantia nigra were either stained with cresyl
violet under standard procedures to evaluate the general tissue
morphology, or processed using immunocytochemistry tech-
niques for the identification of PDE10A-positive neurons and
nerve fibers. Briefly, free-floating sections were washed three
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times in Tris-buffered saline, pH 7.4; endogenous peroxidase
activity was inactivated by incubation for 5 min in Tris-
buffered saline that contained 2% H2O2. Sections were rinsed
with Tris-buffered saline that contained 0.1% Triton X-100,
and incubated with 2% normal goat serum, followed by over-
night incubation at 4°C with the primary antibody rabbit anti-
PDE10A (1:200; FabGennix). The primary antibody was
detected using a biotinylated secondary goat anti-rabbit
antibody (Vectastain ABC kit, Vector Laboratories), and an
avidin-horseradish peroxidase/diaminobenzidine/H2O2 ch-
romogen system (Sigma-Aldrich).
The specificity of the immunocytochemical reaction was
confirmed by the absence of staining after omission of the pri-
mary antibodies. After the diaminobenzidine reaction, sections
were rinsed with Tris-buffered saline, mounted on gelatin-coated
slides, dehydrated, and coverslipped with Permount for light
microscopy examination. Sections were observed and photo-
graphed with a light microscope (Olympus BX51) equipped with
an automatic microcamera (Leica DC 300 F, Q550 IW Soft).
Morphometry and densitometric analysis. To evaluate the rela-
tive number of cells in the striatum, a light microscope was used
(Olympus BX51). This was equipped with a 20 objective and
with an automatic microcamera (Leica DC 300 F, Q550 IW Soft).
An expert operator performed automatic morphological analysis
using Quantimet Image Processing and Analysis System (Q550
IW Soft). Total cell counts per area were performed in two Nissl-
stained sections, including the cross-sectional areas of the stria-
tum of three animals per group (1.4 mm anterior to 0.14 mm
posterior to bregma; Paxinos and Franklin, 2012). The counting
frame (1.35  10 5 m 2) was randomly placed on the counting
area that contained the dorsolateral part of the caudate–puta-
men. The total number of Nissl-stained cells (mean SD) were
counted per unit test area (1.35 10 5 m 2) and were expressed
independently of the hemispheric laterality.
To evaluate the PDE10A content in brain sections, densitom-
etry analysis of PDE10A immunoreaction staining intensity was
evaluated in the different regions of the basal ganglia circuits of
the three groups of animals (five sections per animal, three fields
per area per section), using the Gray Scale Program of the Quan-
timet Image Processing and Analysis System (Q550 IW Soft).
Values were expressed as means SD of immunoreactive optical
density per unit test area (4.5 10 4 m 2) in the caudate–puta-
men, globus pallidus, entopeduncular nucleus, and substantia
nigra.
Double immunofluorescence techniques and confocal micros-
copy. To evaluate distribution of PDE10A and enkephalin (Enk)
in striatal neurons, the double immunofluorescence analysis was
performed; it was targeted to hMT mice, which showed the most
significant PDE10A changes compared with control NT mice in
our study.
Briefly, free-floating sections of the caudate–putamen of three
mice per group, 40m thickness each, were incubated for 72 h at
4°C with a mixture of the following: (1) mouse monoclonal anti-
PDE10A antibody (24F3.F11, generous gift from Pfizer to Dr.
Francesca R. Fusco) diluted 1:1000; (2) a mixture (1:200) of rab-
bit anti-leucine-Enk and rabbit anti-Met-Enk antibodies (Milli-
pore Bioscience Research Reagents). Sections were then rinsed
and subsequently incubated with goat anti-rabbit cyanine Cy2
(Cy2)-conjugated secondary antibody, and goat anti-mouse cya-
nine Cy3 (Cy3)-conjugated secondary antibody 1:50 in PBS
(Jackson Immunoresearch) for 2 h at room temperature. Sec-
tions were mounted on gelatin-coated slides and coverslipped
with Gel Mount.
The dorsolateral caudate–putamen was examined under an
epi-illumination fluorescence microscope (Zeiss Axioskop 2)
and a confocal laser scanning microscope (Zeiss LSM 510) with a
40 objective. PDE10A immunoreactivity was visualized by red
Cy3 fluorescence. Enk immunoreactivity was visualized by green
Cy2 fluorescence. Colocalization of Enk and PDE10A immuno-
reactivity was visualized by merged image in orange-yellow, and
was rated as present or absent.
Enk-positive and Enk-negative cells colocalizing PDE10A
were identified per microscopic field in the dorsolateral caudate–
putamen on three fields per area, three sections per animal, and
three animals per group. The content of PDE10A fluorescence
per cell was evaluated by Java image processing and ImageJ.
Briefly, the cells of interest were selected using a drawing selection
circle around the identifiable neuronal bodies, and the red color
image of PDE10A fluorescence intensity was analyzed by con-
verting each pixel in grayscale (0 –255). The minimum and max-
imum gray values within the selection were detected, and the
mean gray value (the sum of the gray values of all the pixels in the
selection divided by the number of pixels) per cell was calculated.
PDE10A protein quantitative analysis. Western blotting was
used for the quantitative analysis of PDE10A expression in the
caudate–putamen, globus pallidus, substantia nigra, and entope-
duncular nucleus. SDS-PAGE was performed on 9% slab gels
(GE Healthcare), followed by transfer of the proteins to nitrocel-
lulose membranes (Bio-Rad). Blots were incubated overnight at
4°C with rabbit anti-PDE10A antibody (1:2000; FabGennix), or
mouse anti--actin (1:10,000; Sigma-Aldrich) as reference stan-
dard. A secondary goat anti-rabbit IgG alkaline phosphatase (1:
2000; Sigma-Aldrich) was used to reveal PDE10A immune
complexes. Immunoreactive bands were stained with nitroblue
tetrazolium (0.3 mg/ml) in the presence of 5-bromo-4-chloro-3-
indolyl-phosphate (0.15 mg/ml). Densitometry analysis of
scanned blots was performed using the National Institutes of
Health ImageJ version l.29 program.
Phosphodiesterase activity assay. Phosphodiesterase (PDE) ac-
tivity was measured at 30°C for 15 min (linearity period) with the
two-step method described by Thompson and Appelman (1971),
using [ 3H]cAMP (GE Healthcare). Aliquots of tissue extracts
were incubated in 60 mM HEPES, pH 7.2, assay buffer containing
0.1 mM EGTA, 5 mM MgCl2, 0.5 mg/ml bovine serum albumin,
and 30 g/ml soybean trypsin inhibitor, in a final volume of 0.3
ml. The reaction was started by adding tritiated substrate at a final
concentration of 0.1 M [ 3H]cAMP and stopped by adding 0.1
ml of 0.1 M HCl. This low substrate concentration was chosen so
that the activity of PDE with high cAMP affinity could be prefer-
entially detected, like the PDE10A that hydrolyzes cAMP with a
Michaelis constant (Km) of 0.05M but cGMP with aKm of 3M.
To evaluate PDE10A contribution to the total cAMP-PDE activ-
ity, we compared papaverine specificity and potency in inhibiting
cyclic nucleotide hydrolysis in tissue extracts from the different
strains of animals (Siuciak et al., 2006; Giorgi et al., 2011).
RNA extraction and real-time PCR. Total RNA was prepared
using the TRI Reagent (Sigma-Aldrich), according to the manu-
facturer’s instructions. Purified RNA was treated with RNase-free
DNase I (Ambion). Two micrograms of RNA from each sample
were reverse transcribed for 60 min at 37°C with 1.0 g of ran-
dom hexamers (Promega) as primers and 200 U of M-MLV re-
verse transcriptase (Promega).
Real-time PCR was performed on reverse-transcription (RT)
products with the SsoFast EvaGreen Supermix (Bio-Rad) in a
Lightcycler apparatus (Bio-Rad), following the manufacturer’s
instructions. Thermal cycling conditions consisted of an initial
2114 • J. Neurosci., February 22, 2017 • 37(8):2112–2124 D’Angelo, Castelli et al. • Changes to Phosphodiesterase-10A in Dystonia
denaturation step at 95°C for 1 min, followed by 40 cycles at 95°C
for 10 s, 60°C for 10 s, and 72°C for 15 s.
The threshold cycle (Ct), defined as the fractional PCR cycle
number at which fluorescence reaches 10 times the baseline SD,
was used for comparison analysis. The 2Ct method was used
to evaluate the relative expression ratio for PDE10A compared
with internal control gene -actin. The following sequences of
primers were used: PDE10A; forward, 5-CCTCCACAAC-
CAGTCCCATC-3; reverse, 5-CATCACCCTCAGCCCAGAA-
3; -actin: forward, 5-GCGCAAGTACTCTGTGTGGA-3;
reverse, 5-AAGGGTGTAAAACGCAGCT-3.
Statistical evaluation. Data analysis was performed using the
Statistical Package for the Social Sciences Windows, version 15.0
(SPSS). Descriptive statistics consisted of the mean  SD for
parameters with Gaussian distributions (after confirmation with
histograms and the Kolgomorov–Smirnov test). The homogene-
ity of the variance was evaluated by means of Levene’s test. Com-
parison among groups was performed with the ANOVA followed




Nissl-stained sections showed various types of blue-stained neu-
rons and glial cells through the rodent basal ganglia, whereas
bundles of white matter were unstained. Qualitative assessment
of Nissl staining and stereological analysis of total cell number in
the caudate–putamen were compared among the three strains of
animals (n 3 animals per group). The blue staining pattern of
neurons and glial cells in the caudate–putamen was similar
among the three strains of animals (Fig. 1). Moreover, the total
numbers of neurons and glial cells per unit test area (1.35 10 5
m 2) were comparable among the three strains (462.7 32.18 in
NT, 489.7  39.55 in hWT, and 497.2  30.48 in hMT; df  2,
F 1.68, p 0.22).
PDE10A immunohistochemistry in basal ganglia circuits
In control NT mice, intense PDE10A-like brown reaction prod-
uct immunoreactivity was observed in numerous neuronal bod-
ies and in the neuropil, both showing intense staining throughout
the caudate–putamen (Figs. 2A, 3A). Intense PDE10A-like im-
munoreactivity was observed also in nerve fibers within the glo-
bus pallidus (Fig. 3A,D), the entopeduncular nucleus (Fig. 3G),
and the substantia nigra pars reticulata (Fig. 4A). It is worth
noting that, in NT mice, PDE10A immunoreactivity was compa-
rable among the different brain areas, suggesting a balanced
distribution of PDE10A in the striatum and its projection areas
(Figs. 2A, 3A,D,G, 4A).
PDE10A immunoreactivity pattern changed in hWT mice and
especially in hMT transgenic mice: in the caudate–putamen,
PDE10A immunoreactivity appeared increased in some neurons,
but decreased in other adjacent neurons and mainly in the sur-
rounding neuropil (Fig. 2B,C). Moreover, PDE10A immunore-
activity appeared increased in the globus pallidus of hWT and
hMT (Fig. 3E,F) compared with NT mice, but decreased in the
entopeduncular nucleus of hMT mice (Fig. 3I). It also decreased
in the substantia nigra of hWT and hMT mice, compared with
NT mice (Fig. 4B,C).
Densitometric analysis confirmed significant changes of
PDE10A immunoreactivity in the basal ganglia among the three
strains. In the caudate–putamen (Fig. 5), the PDE10A reaction prod-
uct intensity was generally higher mainly in hMT mice and to a lesser
extent in hWT mice, compared with NT mice (df2,F6.965,p
0.05 NT vs hWT and hMT).
In the globus pallidus (Fig. 5), PDE10A immunoreactivity was
higher in hWT (n 6) and hMT (n 5) mice than in NT (n 9)
mice (df 2, F 24.894, p 0.01 NT vs hWT and hMT).
Conversely, in the entopeduncular nucleus, PDE10A immu-
noreactivity was lower (Fig. 5) in hMT (n 5) than in NT (n 9)
mice (df 2, F 4.197, p 0.05 NT vs hMT).
Figure 1. Low-powermicrophotographs of the caudate–putamen. Nissl-stained sections showing neurons and glia, stained in blue, distributed like patches among bundles of unstained white
matter. A, NT mice. B, hWT mice. C, hMT mice. Scale bar, 100m.
Figure 2. A–C, Comparative PDE10A immunohistochemistry in striatal neurons of (A) NT mice, (B) hWT mice, and (C) hMT mice. The white arrows point to striatal neurons with low PDE10A
immunoreactivity; black arrowspoint to striatal neuronswithhighPDE10A immunoreactivity.Nuclei of neurons, small bloodvessels, andbundles ofwhitematter appear lightly stainedorunstained.
Scale bar, 50m.
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Moreover, PDE10A immunoreactivity was also lower in the
substantia nigra pars reticulata (Fig. 5) of both hMT (n 5) and
hWT (n  6) compared with NT (n  9) mice (df  2, F 
40.451, p 0.05 NT vs hWT, p 0.01 NT vs hMT, and p 0.01
hWT vs hMT).
PDE10A and Enk double immunofluorescence
We hypothesized that the upregulation of PDE10A in striatal
neurons of hMT mice would be selective for a subpopulation of
neurons projecting to the external segment of the globus pallidus
and likely containing Enk (Beckstead and Kersey, 1985).
In control NT mice, PDE10A immunofluorescence was ob-
served in the vast majority of the striatal neurons, with similar
intensity in the cell bodies and in the neuropil; however, indi-
vidual neurons were characterized by a strong PDE10A immu-
nofluorescence in the cytoplasm around the nucleus, which
was invariably unstained (Fig. 6), as shown by Coskran et al.
(2006).
Moreover, some neurons exhibited Enk-like immunofluores-
cence combined within the nucleus and the cytoplasm (Fig. 6),
which is consistent with reports in rats, monkeys, and humans (Mc-
Collum et al., 2012). The morphological characteristics and distri-
bution of Enk-positive cells in the striatum of NT and hMT mice
(n  3 mice in each group) were comparable (Fig. 6), as similarly
reported in genetically dystonic hamsters (Kreil et al., 2011).
Colocalization of PDE10A and Enk in neurons of the dorsal
striatum demonstrated that 100% of Enk-positive neurons were
also PDE10A-positive, but only 36 –39% of PDE10A-positive
neurons per microscopic field were labeled also for Enk both in
NT and hMT mice. These data are consistent with the notion that
virtually all PDE10A-positive neurons in the striatum are me-
dium spiny projection neurons, but only approximately half of
the medium spiny neurons are Enk-positive (Besson et al., 1990;
Xie et al., 2006).
Surprisingly, in NT control animals, the content of PDE10A is
different between the different neuronal subpopulations. Indeed,
Figure 3. A–I, Microphotographs of PDE10A immunohistochemistry, comparing the brown reaction product intensity of the basal ganglia among (A,D, G) NTmice, (B, E,H ) hWTmice, and (C,
F, I ) hMT mice. Low-power microphotographs of the caudate–putamen (CP) and globus pallidus (GP) (A–C); plexus of PDE10A nerve fibers in the GP (D–F ); plexus of PDE10A nerve fibers in the
entopeduncular nucleus (G–I ). Scale bars: C, 100m; F, I, 20m.
Figure 4. A–C, Low-powermicrophotographs of PDE10A immunohistochemistry, comparing the brown reaction product intensity in the substantia nigra amongNTmice (A), hWTmice (B), and
hMTmice (C). Scale bar, 100m.
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quantitative analysis of PDE10A per cell demonstrates that in NT
striatal neurons the relative PDE10A immunofluorescence inten-
sity was higher in Enk-negative compared with the Enk-positive
neurons detected in the same microscopic fields (df  1, F 
4.604, p 0.05; Fig. 7).
Furthermore, in hMT mice, the Enk-positive neurons dis-
played a selective increase of PDE10A immunofluorescence (df
1, F  5.599, p  0.02), whereas in the same microscopic fields
the Enk-negative neurons had a slight nonsignificant PDE10A
decrease, compared with the correspondent neuronal subpopu-
lations in NT mice (Fig. 7). Therefore, the PDE10A content in
Enk-positive neurons was as intense as in Enk-negative neurons
of hMT mice, unlike the results in the NT mice (Fig. 7).
PDE10A protein expression in basal ganglia circuits
To evaluate further the relative intensity of PDE10A expression in
the different groups of animals, Western blot analysis was per-
formed using a specific polyclonal antibody on tissue extracts
from different areas of the basal ganglia. In the three strains of
animals, a single band of 88 Kda PDE10A immunoreactivity was
detected in tissue extracts from the different brain regions (Fig.
8), according to Seeger et al. (2003).
In NT control mice, PDE10A expression intensity was similar
in the caudate–putamen, globus pallidus, and entopeduncular
nucleus as per immunohistochemical results, but its intensity was
higher in the substantia nigra pars reticulata (Figs. 5, 8). The
higher content of PDE10A per milligram of protein in the sub-
stantia nigra could probably be due to the relatively more homo-
geneous anatomical distribution of the PDE10A content in this
region (Fig. 4) than in the striatum, globus pallidus, and entope-
duncular nucleus (Fig. 3), characterized instead by the intermin-
gled distribution of gray and white matter.
In hWT (n 6) and hMT (n 6) mice, no significant differ-
ences in PDE10A expression were detected in the caudate–puta-
men compared with NT control mice (n 6; df 2, F 2.199,
p 	 0.3 NT vs hWT and hMT; Fig. 8). However, as seen in im-
munohistochemical results, hMT mice showed an increased
PDE10A expression in the globus pallidus (Fig. 8), compared
with NT and hWT mice (df 2, F 12.277, p 0.01 hMT vs NT
and hWT). Conversely, PDE10A expression in hMT mice was
decreased in the entopeduncular nucleus (df 2, F 8.588, p
0.01 NT vs hMT), and in the substantia nigra (df 2, F 4.399,
p  0.05 NT vs hMT; Fig. 8). Therefore, the significant differ-
ences between NT and hMT experimental groups detected by
immunohistochemistry are confirmed by the quantitative West-
ern blotting analysis in the globus pallidus, entopeduncular nu-
cleus, and substantia nigra, demonstrating that data from
Western blotting are precise and reliable in these areas but not in
the caudate–putamen.
Moreover, PDE10A levels in the hWT mice are intermediate in
expression between those of NT and hMT mice, as detected by im-
munohistochemistry and Western blotting in the different basal
ganglia regions. However, the significant changes detected by immu-
nohistochemistry in hWT mice compared with NT mice were not
confirmed by the more variable values obtained by Western blotting
analysis. This discrepancy would suggest that immunohistochemis-
try could be more sensitive than Western blotting to detect subtle
changes in PDE10A. Indeed, immunohistochemistry can catch both
membrane-bound and cytosol-soluble PDE10A isoforms in tissue
(Charych et al., 2010), whereas in our experimental setting the West-
ern blotting would preferentially detect cytosol-soluble PDE10A iso-
forms after extraction with low concentration of Triton X-100
(0.1%). Future studies should evaluate possible selective changes
between membrane-bound and cytosol-soluble PDE10A isoforms,
differentiating PDE10A subcellular distribution in NT, hWT, and
hMT mice.
PDE and PDE10A activities
We investigated whether changes in PDE10A expression in hMT
mice and, to a lesser extent, in hWT mice consistently affected
total cAMP-PDE activity and PDE10A-dependent cAMP hydro-
lyzing activity in tissue extracts. Total cAMP-PDE activity was
evaluated as nmol cAMP hydrolyzed to inactive 5AMP/min/mg
protein. We used PDE10A selective inhibitor papaverine at a
fixed concentration of 0.2 M (Siuciak et al., 2006; Giorgi et al.,
2011) to evaluate PDE10A-dependent cAMP hydrolyzing activity
Figure 5. Comparative densitometric analysis of the PDE10A immunohistochemistry optical density (O.D.) per unit test area in different basal ganglia regions [caudate–putamen (CP), globus
pallidus (GP), entopeduncular nucleus (EN), substantia nigra (SN)] of NT, hWT, and hMTmice. Values are expressed asmeans SD of immunoreactive optical density per unit test area (4.5 10 4
m2) in NT (n 9), in hWT (n 6), and in hMT (n 5) mice. CP: df 2, F 6.965; GP: df 2, F 24.894; EN: df 2, F 4.197; SN: df 2, F 40.451. One-way ANOVA followed by
Bonferroni’s correction for multiple comparison. *p 0.05, **p 0.01.
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in tissue extracts of different brain areas. The rate of papaverine-
inhibited PDE activity was assessed as the difference between the
total and the papaverine-resistant PDE activity in each region of
the different groups of animals.
Total cAMP-PDE activity
Total cAMP-PDE activity in tissue extracts from the caudate–
putamen was similar in the three strains (n 6 in each group) of
animals (Fig. 9; df 2, F 0.554, p	 0.9 NT vs hWT and hMT).
However, total PDE activity was significantly increased in the
globus pallidus of hMT mice (df 2, F 7.642, p 0.01 NT vs
hMT), but significantly decreased in the entopeduncular nucleus
of both hWT and hMT mice (df 2, F 6.748, p 0.05 NT vs
hWT and hMT; Fig. 9). Moreover, a nonsignificant decrease of
total cAMP-PDE activity was detected in the substantia nigra of
both hWT and hMT mice (df 2, F 0.772, p 0.7 NT vs hWT
and hMT; Fig. 9).
Papaverine-sensitive PDE activity
According to the values of total PDE activity, the amount of papav-
erine-sensitive PDE activity (n 6 in each group) in tissue extracts
from the caudate–putamen was similar in the three strains of ani-
Figure 6. A–F, Confocal laser-scanning microscopy images of double-labeled immunofluorescence for PDE10A and Enk in NT (A, C, E) and hMT (B, D, F ) mice. PDE10A immunolabeling is
visualized by red-Cy3 fluorescence (A, B); Enk immunolabeling is visualized in green-Cy2 fluorescence (C, D); the merged images are shown in E and F. The white arrows show somemedium spiny
projection neurons positive for both PDE10A and Enk, whereas white arrowheads point to some neurons positive for PDE10A, but negative for Enk. Scale bar, 50m.
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mals. However, papaverine-sensitive PDE activity per milligram of
protein was significantly increased in the globus pallidus of hMT
(df  2, F  8.794, p  0.01 and p  0.05 hMT vs NT and hWT
respectively; Table 1), but at the same time it was significantly de-
creased in the entopeduncular nucleus of hWT and hMT mice (df
2, F 5.325, p 0.05 NT vs hWT and hMT; Table 1). Instead, the
amount of papaverine-sensitive cAMP-PDE activity in the substan-
tia nigra was not significantly different for the three strains of animals
(df 2, F 0.578, p	 0.5; Table 1).
Therefore, the total cAMP-PDE activity and papaverine-
sensitive cAMP-PDE activity are either increased or decreased,
respectively, in the globus pallidus and in the entopeduncular
nucleus, consistent with the Western blot PDE10A expressions in
the different basal ganglia areas in each group of animals. The
inconsistent relationship between the significant decrease of
PDE10A expression selectively expressed in the substantia nigra
pars reticulata and the highly variable nonsignificant changes in
the total and papaverine-inhibited cAMP-PDE activity is proba-
bly due to the interference of other PDE isoforms in the sur-
rounding structures (Lakics et al., 2010). These, indeed, cannot
easily be dissected from the substantia nigra pars reticulata be-
cause of the small size and anatomical complexity of the region.
Papaverine-resistant cAMP-PDE activity
To evaluate further the contribution of PDE10A to the total PDE
activity, we compared the values of papaverine-resistant cAMP-
PDE activity in the different basal ganglia structures. The rela-
tionship between total PDE activity and papaverine-resistant
PDE activity was highly significant in the caudate–putamen (Fig.
9) for the three strains of animals (df  5, F 25.958, p 0.01
total PDE vs papaverine-resistant PDE), suggesting that the con-
tribution of PDE10A per milligram of
protein is higher in the caudate–putamen
than in the globus pallidus and the en-
topeduncular nucleus. Moreover, a signif-
icant relationship between total PDE
activity and papaverine-resistant PDE ac-
tivity was observed only in the hMT glo-
bus pallidus (df 5, F 8.984, p 0.01),
but not in the entopeduncular nucleus
(df  5, F  6.377, p  0.5) and in the
substantia nigra (df  5, F  2.309, p 	
0.6). It is noteworthy, instead, that the
amount of papaverine-resistant cAMP-
PDE activity is similar in the caudate–pu-
tamen (Fig. 9) for the three strains of
animals, but it was significantly lower in
the entopeduncular nucleus of hWT and
hMT mice compared with NT mice (df
2, F  6.875, p  0.05 NT vs hWT and
hMT; Fig. 9). These data suggest that the
increase and decrease of total PDE activity
in the globus pallidus and entopeduncular
nucleus, respectively, are likely due to the
concordant changes of PDE10A activity in
the same structures.
PDE10A mRNA
RT-PCR amplification of PDE10A mRNA
was performed in the different groups of an-
imals to investigate PDE10A changes at the
transcriptional level in basal ganglia. The
primers, which amplified a specific mRNA
fragment (140 bp), gave a strong PDE10A
signal in the caudate–putamen of NT mice (n 5; Fig. 10A). How-
ever, in agreement with the results of Seeger et al. (2003), PDE10A
mRNA was not detected at all, or just in low amounts, in the globus
pallidus, entopeduncular nucleus, and substantia nigra (Fig. 10B).
The pattern and relative intensity of PDE10A mRNA expression
detected in the caudate–putamen of NT mice were similar in the
caudate–putamen of both hWT and hMT mice (Fig. 10A).
Discussion
The main findings of our work are the differential changes to
PDE10A that occur in the striatal neurons’ subpopulations of
hMT mice, associated with increased or decreased PDE10A ex-
pression and activity respectively in the globus pallidus and in the
entopeduncular nucleus/substantia nigra.
It is noteworthy that changes to PDE10A occur also in basal
ganglia circuits of hWT mice, but to a lesser extent than in hMT
mice. Our data are in agreement with the work of Grundmann et
al. (2007), which showed that neuropathological, neurochemical,
and behavioral abnormalities occur not only in hMT mice, but
also in hWT mice. However, the most significant PDE10A
changes are observed in hMT mice, suggesting that mutant tor-
sinA can have more severe consequences on neuronal dysfunc-
tions than hyperexpression of wild-type torsinA.
Such changes to PDE10A in the indirect and direct pathways
are specific to hMT mice; experimental parkinsonism in rat is
indeed characterized by decreased PDE10A protein levels and
activity in striatal neurons as well as in striatopallidal and stria-
tonigral projections (Giorgi et al., 2011).
Figure 7. Comparative densitometric analysis of PDE10A immunofluorescence intensity colocalized in Enk-positive (ENK
)
and Enk-negative (ENK) neurons of the dorsolateral striatum in NT and hMTmice. Results were expressed as themean SD of
average gray values (0–255)within the selected cells of the dorsolateral caudate–putamen of both hemispheres from threemice
in each group. One-way ANOVA followed by Bonferroni’s test for multiple comparisons. Comparisons within groups NT and hMT,
and between groups NT	 hMT: *p 0.05, **p 0.02.
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PDE10A expression patterns in the caudate–putamen
neurons
We investigated whether the upregulation and downregulation
of PDE10A immunoreactivity among the striatal neurons would
be selective for the striatopallidal and striatoentopeduncular/ni-
gral neurons of hMT mice, containing respectively Enk or sub-
stance P (Beckstead and Kersey, 1985). This study has some
limitations that must be pointed out.
The immunohistochemistry of substance P striatal projec-
tion neurons was not included in this study because a reliable
immunostaining of substance P-positive perikaria was difficult to
achieve in mice (data not shown) without intraventricular col-
chicine pretreatment, which blocks the axonal transport (Beck-
stead and Kersey, 1985; Reiner et al., 1988). Therefore, the
PDE10A-positive/Enk-negative neurons were presumably iden-
tified as the striatoentopeduncular/nigral projection neurons.
Our data demonstrate that the increased PDE10A immuno-
reactivity in striatal neurons of hMT mice is expressed only in
Enk-positive striatal neurons, displaying concordant PDE10A in-
crease in the projections to the globus pallidus.
Conversely, densitometry analysis in Enk-negative neurons of
hMT mice did not show significant changes in PDE10A immu-
noreactivity within the neuronal bodies throughout the dorsolat-
eral striatum, even though their presumed projections to the
entopeduncular nucleus and substantia nigra display reduced
PDE10A expression and activity compared with those of NT
mice. Therefore, we cannot link with certainty the reduction of
PDE10A in striatoentopeduncular-nigral projections of hMT
mice to concordant PDE10A changes in the neuronal body of
Enk-negative striatal neurons.
However, we note that qualitative analysis of PDE10A immu-
nohistochemical staining in the striatum reveals reduced immu-
noreaction product mainly in the neuropil of hMT mice. Instead,
densitometry analysis of PDE10A fluorescence evaluated by us-
ing the Java image processing is technically focused on the neu-
ronal bodies, the area where PDE10A immunoreaction can be
attributed with some certainty either to Enk-positive or Enk-
negative neurons. Therefore, selective changes of PDE10 in the
neuropil of a specific neuronal subpopulation could be missed in
immunofluorescence analysis.
Moreover, unlike the differentiated immunohistochemical
data collected in neuronal subpopulations of the caudate–puta-
men, PDE10A expression and activity were similar in the cau-
date–putamen homogenates among the three strains of mice.
The difference between morphological and biochemical data in
the striatum could be explained by the observation that tissue
homogenates cannot detect the differentiated changes between
neuropil and neuronal bodies present in the same areas. There-
Figure 8. A, Comparative densitometry optical density (O.D.) of PDE10AWestern blotting bands in correspondent areas of the basal ganglia of NT, hWT, and hMTmice. Results were expressed
as themean SD of values obtained fromboth hemispheres from sixmice in each group. CP, caudate–putamen (df 2, F 2.199); GP, globus pallidus (df 2, F 12.277); EN, entopeduncular
nucleus (df 2, F 8.588); SN, substantia nigra (df 2, F 4.399). One-way ANOVA followed by Bonferroni’s test for multiple comparisons. *p 0.05, **p 0.01. B, Representative
immunoblots of PDE10A protein content in the CP, GP, EP, and SN of NT, hWT, and hMTmice.-Actin was used as the internal reference standard.
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fore, the subcellular distribution of PDE10A should be further
investigated to fully document PDE10A changes in neuronal
bodies, dendrites, and terminals of Enk-negative and Enk-
positive neurons in hMT mice.
Finally, we have demonstrated that the PDE10A mRNA
expression was similar in the three strains, suggesting that the
changes of PDE10A expression and activity in hWT and hMT
mice occur at the post-transcriptional level. Therefore, the neu-
rochemical relationship between the mutant torsinA protein and
the different changes of PDE10A in Enk-positive and in Enk-
negative neurons is unknown. One should consider the possibil-
ity that mutant torsinA protein in hMT mice determines variable
expression of PDE10A in striatal circuits in the context of a mo-
saic of abnormal striatal plasticity (Quartarone and Pisani, 2011).
Role of PDE10A upregulation and downregulation in striatal
projection neurons
In previous work we demonstrated that the cAMP levels are ei-
ther increased or decreased in a rat experimental model of par-
kinsonism according to the downregulation or upregulation of
PDE10A expression and activity, respectively, in neurons of the
caudate–putamen and nucleus accumbens (Giorgi et al., 2011).
The inverse changes to PDE10A in the striatal indirect and direct
pathways of hMT mice can affect the rate of catabolism of second
messenger cAMP and cGMP, differentially modulating the func-
tions of basal ganglia circuits, not only in the striatum but also in
its projection areas (Threlfell et al., 2009; Threlfell and West,
2013; Padovan-Neto et al., 2015). Several studies indicate the
importance of presynaptic cAMP signaling/degradation in the
control of striatonigral and striatopallidal projections and
in other areas. Indeed, the modulation of neural transmission can
occur also at synaptic terminals independent of the propagation
of action potentials triggered by excitation of cell bodies to the
terminals (Shindou et al., 2002; Fourcaudot et al., 2008; Mango et
al., 2014).
The cAMP synthesis in striatal neurons is stimulated by
dopamine D1 receptors, mainly expressed in the GABAergic pro-
jection neurons of the direct pathway, and by adenosine A2A
receptors, mainly expressed in the GABAergic projection neu-
rons of the indirect pathway (Cooper, 2003; Schiffmann et al.,
2007). In addition, dopamine D2 receptors, mainly expressed in
the GABAergic projection neurons of the indirect pathway (Que-
rejeta et al., 2001; Cooper, 2003), inhibit cAMP synthesis and
tightly interact structurally and functionally with the A2A recep-
tors, exhibiting reciprocal antagonistic interactions (Ferre´ et al.,
1997; Salmi et al., 2005). Furthermore, the dopamine D1 and D2
receptors also stimulate or inhibit cGMP synthesis, respectively
(Cooper, 2003; Sammut et al., 2006, 2007). Therefore, functional
relevance of the inverse PDE10A changes in hMT mice could be
unraveled in the context of the complexity of basal ganglia cir-
cuits and of D1, A2A, and D2 interactions.
Actually, PDE10A, by hydrolyzing cAMP, can regulate the
amplitude and the duration of cAMP/PKA signaling stimulated
Figure9. Total PDE activity (dark gray columns) and papaverine-resistant PDE activity (light
gray columns) in the caudate–putamen (CP), globus pallidus (GP), entopeduncular nucleus
(EN), and substantia nigra (SN) of NT, hWT, and hMT mice; n  6 in each group. A fixed
papaverine concentration (0.2M) was used to allow comparison of the papaverine-resistant
PDE activity between the correspondent brain regions in the different experimental groups.
Values are expressed as nmol cAMPhydrolyzed/min/mgproteins SD. CP: df 2, F 0.554;
GP: df2, F7.642; EN, df2, F6.748; SN: df2, F0.772.One-wayANOVA followed
by Bonferroni’s correction for multiple data. CP: **p 0.01 total versus papaverine-resistant
PDE activity in each group. GP: **p 0.01 total PDE activity in NT versus hMT; **p 0.01 total
versus papaverine-resistant PDE activity in hMT group. EN: *p 0.05 NT versus hWT, and
**p 0.01 NT versus hMT. SN: p	 0.6 NT versus hWT and hMT.
Table 1. Papaverine-inhibited PDE activity in different regions of the basal ganglia
in NT, hWT, and hMTmice
Brain region NT hWT hMT
Caudate–putamen 0.878 0.136 0.743 0.179 0.755 0.141
Globus pallidus 0.034 0.014 0.046 0.016* 0.088 0.035**
Entopeduncular nucleus 0.054 0.026 0.028 0.009* 0.020 0.013*
Substantia nigra 0.37 0.28 0.26 0.11 0.22 0.17
Total PDE activity was assayed in the presence of 0.1M cAMP; papaverine-inhibited PDE activity was evaluated
after adding a fixed dose of papaverine (0.2 M). PDE activity was detected as nmol cAMP hydrolyzed/min/mg
protein. Papaverine-inhibited PDE activity was calculated as the difference between the basal PDE activity and the
residual PDE activity assayed in the presence of papaverine. N 6 in each group. One-way ANOVA followed by
Bonferroni’s correction formultiple data. Caudate–putamen: no significant differences between NT, hWT, and hMT
mice; globus pallidus: **p 0.01 NT versus hMT, *p 0.05 hWT versus hMT; entopeduncular nucleus: *p 0.05
NT versus hWT, and versus hMT; substantia nigra: no significant differences between NT, hWT, and hMTmice.
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by dopamine D1 receptors, finally leading to the inhibition of the
D1-dependent stimulator signaling in the direct striatoentope-
duncular neurons (Nishi et al., 2008). Moreover, PDE10A also
can limit the amplitude and the duration of the cAMP/PKA sig-
naling stimulated by adenosine A2A, finally leading to the poten-
tiation of dopamine D2 inhibitor signaling in the indirect
striatopallidal neurons (Nishi et al., 2008). In addition, PDE10A
activity can modulate amplitude and duration of cGMP signals in
the striatum, either stimulated by D1 or downregulated via D2
receptor-dependent mechanisms, limiting excitatory corticos-
triatal transmission (Padovan-Neto et al., 2015).
Our observations that PDE10A expression is downregulated
in the direct striatoentopeduncular/substantia nigra pathway of
hMT mice suggest that amplitude and duration of cAMP/cGMP
signals (induced by D1 receptors) are increased because of re-
duced PDE10A activity, at least in the striatonigral and stria-
toentopeduncular terminals. On the other hand, the PDE10A
upregulation in the indirect striatopallidal pathway of hMT mice
suggests that amplitude and duration of cAMP signals (stimu-
lated by adenosine A2A receptors) are reduced because of in-
creased PDE10A activity, both in the neuronal bodies and in their
projections, thus potentiating D2 receptor-mediated inhibition
of cAMP/cGMP signals.
Therefore, the inverse changes of PDE10A in striatoentope-
duncular and striatopallidal pathway of hMT mice may affect at a
given time the functions of the D1 and D2 receptors, determi-
ning an increase in amplitude and duration of cAMP/cGMP-
stimulated or cAMP/cGMP-inhibited signals in the direct and
indirect pathways, respectively. Our results reflect a recently pro-
posed model of dysfunction of basal ganglia circuits, suggesting
that changes in both indirect and direct pathways would disrupt
functions in the basal ganglia–thalamus– cortex motor circuit
and ultimately the ability to focus movements properly (Hendrix
and Vitek, 2012).
Previous experimental evidence from animal models of dysto-
nia indicates a crucial role for striatal cholinergic interneurons in
the pathophysiology of dystonia (Pisani et al., 2006; Sciamanna et
al., 2009, 2011, 2012). Moreover, electrophysiological data in
hMT mice demonstrate a disinhibition of striatal GABAergic syn-
aptic activity that can be partially attributed to a D2 dopamine
receptor dysfunction (Sciamanna et al., 2009). Interestingly, the
impairment of D2 receptor-dependent synaptic plasticity,
observed in hMT mice, was fully restored by pharmacological
blockade of adenosine A2A receptors (Napolitano et al., 2010),
raising the question as to whether PDE10A upregulation in stri-
atopallidal projections of hMT mice could be a compensatory
mechanism to altered reciprocal antagonistic interactions be-
tween adenosine A2A and dopamine D2 receptors. Furthermore,
DYT1 transgenic mice exhibit significantly decreased striatal D1
receptor binding activity and protein levels, suggesting that along
with the D2 indirect pathway, the direct pathway is also affected
(Yokoi et al., 2015).
In conclusion, our study demonstrates opposing PDE10A
changes in the striatopallidal and striatoentopeduncular connec-
tions, suggesting a widespread involvement of striatal neuronal sub-
types in the pathophysiology of dystonia. The inverse changes of
PDE10A in basal ganglia circuits of hMT mice can determine at a
given time an increased intensity and duration of both D1 receptor-
stimulated and D2 receptor-inhibited cAMP/PKA and cGMP sig-
naling cascades, respectively, in the direct and indirect pathways.
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